ASX:TTB

Total Brain (TTB) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
126,326 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TTB stock logo

About Total Brain Stock (ASX:TTB)

Total Brain Limited operates as an applied integrative neuroscience company in the United States and Australia. The company offers Total Brain, a mental health monitoring and support platform, that helps users to measure their brain capacities while managing the risk of common mental conditions. It serves companies, providers, affinity groups, and precision medicine sectors. The company was formerly known as Brain Resource Limited and changed its name to Total Brain Limited in December 2018. Total Brain Limited was incorporated in 2000 and is based in Surry Hills, Australia.

TTB Stock News Headlines

The Next Step of Their Control Is Here …
Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.
Where To Find The Elder Brain In BG3
Heat harms the brain more than we think
The Next Step of Their Control Is Here …
Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.
6 Brain Exercises For Older Adults
Your Guide To The Best Brain Supplements
See More Headlines
Receive TTB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Total Brain and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
29
Year Founded
N/A

Profitability

Net Income
$-14,500,000.00
Net Margins
-172.26%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.42 million
Book Value
A$0.08 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.37
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Evian Gordon BSc (Hons)
    M.D., MBBCh, Ph.D., Founder & Exec. Chairman
  • Mr. Matthew Mund
    MD, COO, Interim CEO & Director
  • Mr. Louis Gagnon
    Advisor
  • Ms. Donna Palmer
    Chief Science Officer
  • Mr. Marcel Legrand
    Head of Revenue & Corp. Devel.
  • Mr. Matt Resteghini
    Chief Marketing Officer
  • Mr. Simon Poidevin A.M. (Age 64)
    BSc (Hons), OAM, Pres of Australia & New Zealand
  • Mr. Phillip Hains B Bus (Age 62)
    C.A., CA, M.B.A., MBA, Joint Company Sec.
  • Mr. Nathan Jong C.A.
    Joint Company Sec.

This page (ASX:TTB) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners